ACTA1 and cancer: However, according to the recent results of Ogawa et al. regarding the distinct stroma types based on stromal heterogeneity, patients with collagen-rich cancer stroma showed decreased MMP gene expression levels with longer survival compared with other patients with cancer stroma highly expressing CAF markers such as α-SMA or FAP [20].